Initial high-efficacy disease-modifying therapy in multiple sclerosisMathias Due Buron, Melinda Magyari, Thor Ameri Chalmer et al.|Neurology|2020Cited by 160
Alemtuzumab treatment in Denmark: A national study based on the Danish Multiple Sclerosis RegistryÁsta Theódórsdóttir, Zsolt Illés, Finn Sellebjerg et al.|Multiple Sclerosis Journal|2021Cited by 21
Clinically stable disease is associated with a lower risk of both income loss and disability pension for patients with multiple sclerosisThor Ameri Chalmer, Melinda Magyari, Mathias Due Buron et al.|Journal of Neurology Neurosurgery & Psychiatry|2019Cited by 20
Discontinuation of dimethyl fumarate in multiple sclerosis - a nationwide studyMalte Roar, Tobias Sejbæk, Finn Sellebjerg et al.|Multiple Sclerosis and Related Disorders|2023Cited by 3